Atlas Trials

Anterogen Co., Ltd.

31 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Anterogen Co., Ltd.

RecordFirmDate
Clinical Study to Evaluate Efficacy and Safety of ANT-301 in Patients With Knee Osteoarthritis in Grade III/IV by K/L (NCT06539429)Anterogen Co., Ltd.2024-10-22
Study to Evaluate Safety and Efficacy of ALLO-ASC-SHEET in Subjects With Dystrophic Epidermolysis Bullosa (NCT05157958)Anterogen Co., Ltd.2023-05-01
A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-302 Clinical Trial (NCT06141811)Anterogen Co., Ltd.2023-04-25
Clinical Study of ALLO-ASC-SHEET in Subjects With Diabetic Wagner Grade II Foot Ulcers (NCT04497805)Anterogen Co., Ltd.2020-09-08
Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Wagner Grade 2 Foot Ulcers. (NCT04569409)Anterogen Co., Ltd.2020-07-14
A Follow-up Study to Evaluate the Safety of ALLO-ASC-DFU in ALLO-ASC-DFU-301 Clinical Trial (NCT04590703)Anterogen Co., Ltd.2020-06-24
Clinical Study to Evaluate Efficacy and Safety of ASC and Fibringlue or Fibringlue in Patients With Crohn's Fistula (NCT04612465)Anterogen Co., Ltd.2020-01-09
Clinical Study of ALLO-ASC-SHEET in Subjects with Diabetic Foot Ulcers (NCT03754465)Anterogen Co., Ltd.2019-01-02
Clinical Study to Evaluate Efficacy and Safety of ALLO-ASC-DFU in Patients With Diabetic Foot Ulcers. (NCT03370874)Anterogen Co., Ltd.2018-06-27
A Follow-up Study to Evaluate the Efficacy and Safety of ALLO-ASC-DFU in ALLO-ASC-EB-101 Clinical Trial (NCT03183934)Anterogen Co., Ltd.2017-12-08

Track Anterogen Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.